The Oncology Institute, Inc. (TOI) Misses Q4 EPS by 6c

The Oncology Institute, Inc. (NASDAQ: TOI) reported Q4 EPS of ($0.14), $0.06 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $100.27 million versus the consensus estimate of $109.15 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Yatsen Holding (YSG) Reports Q2 Loss of $0.16
• Ciena (CIEN) call put ratio 1 call to 1.6 puts into quarter results